Watch DeviceTalks host Tom Salemi interview Steve Sandweg CEO and Dr. David Meerkin CMO as they discuss how Valcare’s AMEND™ TMVr Annuloplasty System is re-engineering mitral valve repair.  Register here to gain immediate access to view the webinar recording.

Webinar Overview

Surgical Annuloplasty has long been the gold standard for restoring mitral valve function. But until now, replicating that level of anatomical precision through a catheter-based approach has remained one of structural heart’s toughest challenges.

In this webinar, DeviceTalks explores the work behind Valcare Medical’s AMEND™ Transcatheter Mitral Valve RepairSystem, a proprietary investigational transcatheter mitral annuloplasty system designed to perform surgical-like mitral repair.

Topics covered:

  • Unmet needs with existing transcatheter mitral valve repair.
  • Annuloplasty is base technique in almost all surgical mitral repair irrespective of base pathology.
  • About the proprietary design of the AMEND™ TMVr Annuloplasty System.
  • Where this technology fits in the evolving transcatheter mitral repair ecosystem.